Unlike past pharmaceutical litigation, lawsuits over allegations that women's use of Zoloft during their pregnancies caused birth defects in their children are coalescing in federal court instead of state courts across the country, a defense attorney for drugmaker Pfizer said during a multidistrict litigation court hearing Monday.
Lion's Share of Zoloft Litigation Shifting to Federal Court
The Legal Intelligencer
December 4, 2012
This article requires premium access
This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.